Fig. 5From: Nanoarchitectured conjugates targeting angiogenesis: investigating heparin-taurocholate acid conjugates (LHT7) as an advanced anti-angiogenic therapy for brain tumor treatmentEx vivo anti-angiogenic effect analysis. a Rat aorta ring assay in the presence of VEGF and LHT in the concentration range of 0–100 μg/mL. b Quantification analysis for micro-vessel sprouting. Data are expressed as mean ± SEM (n = 5)Back to article page